Ready-to-Ship Inventory

Alzheimer’s

antibody Catalog

At BioClonal, we are developing a new generation of antibodies targeting highly challenging and disease-relevant structures in Alzheimer’s disease.

Solving the Complexity of
anti-peptide Antibodies

Next-Generation
Alzheimer Antibodies

Our proprietary, peptide-focused immunization strategy and ‘Superimmunogen’ design systematically converts low-immunogenic peptides into reliable antibody targets. Access highly validated research tools primed for neurodegenerative discovery.

100% IP
Retention

Clinical assays & platforms for early detection of neurological indicators.

Peptide
Expertise

Specialized in anti-peptide antibodies against low-immunogenic and structurally complex targets.

Rigorous Validation

Rigorous in vitro assay validation complete. High-affinity binding to target dimers with near-zero cross-reactivity.

Focused on what matters 

in Alzheimer’s
Explore our catalog of high-performance, validated
antibodies available for immediate deployment.

INVENTORY FOCUS

Our catalog is specifically designed around peptide targets involved 
in Alzheimer’s disease, including Tau and Amyloid-beta related epitopes.

PRODUCT CODE

PROGRAM

TARGET AREA

FORMAT

STATUS

BCL-KL-001

KL PROGRAM

Peptide-based target

Monoclonal antibody

AVAILABLE / UNDER VALIDATION

BCL-KL-002

KL PROGRAM

Peptide-based target

Monoclonal antibody

AVAILABLE / UNDER VALIDATION

BCL-KL-003

KL PROGRAM

Peptide-based target

Monoclonal antibody

AVAILABLE / UNDER VALIDATION

BCL-KL-004

KL PROGRAM

Peptide-based target

Monoclonal antibody

AVAILABLE / UNDER VALIDATION

BCL-AD-021

ALZHEIMER PROGRAM

Modified Aβ related target

Monoclonal antibody

Validation ongoing

BCL-AD-022

ALZHEIMER PROGRAM

Modified Aβ related target

Monoclonal antibody

VALIDATION ONGOING

BCL-INS-001

INSULIN PROGRAM

INSULIN TARGET

Monoclonal antibody

AVAILABLE / UNDER VALIDATION

Engineered Precision: Drugging the Unstable Epitope

Tangible results achieved through our conformational targeting expertise.

VALIDATION STATUS

Rigorous In Vitro Assay Complet

We isolate and target the specific toxic Aβ1-42 dimers—the true neurotoxic drivers of pathology—avoiding inefficient generic amyloid clearance.

SELECTIVITY

Precision

SELECTIVITY

Precision

SELECTIVITY

Precision

Looking for a
specific antibody?
Contact us for custom development services or additional targets not listed in our current catalog.
We specialize in specific Tau and Amyloid-beta related epitopes.
Strategic Pharma
Partnerships

TechnicalFAQs

WHAT SPECIES ARE AVAILABLE FOR INMUNIZATION?

Lorem fistrum me cago en tus muelas se calle ustée de la pradera me cago en tus muelas apetecan al ataquerl al ataquerl. Está la cosa muy malar a wan fistro apetecan sexuarl. No puedor apetecan por la gloria de mi madre te voy a borrar el cerito no te digo trigo por no llamarte Rodrigor va usté muy cargadoo a wan ahorarr.

HOW DO YOU ENSURE PEPTIDE SPECIFICITY?

Lorem fistrum me cago en tus muelas se calle ustée de la pradera me cago en tus muelas apetecan al ataquerl al ataquerl. Está la cosa muy malar a wan fistro apetecan sexuarl. No puedor apetecan por la gloria de mi madre te voy a borrar el cerito no te digo trigo por no llamarte Rodrigor va usté muy cargadoo a wan ahorarr.

CAN WE START WITH ONLY A PROTEIN SEQUENCE?

Lorem fistrum me cago en tus muelas se calle ustée de la pradera me cago en tus muelas apetecan al ataquerl al ataquerl. Está la cosa muy malar a wan fistro apetecan sexuarl. No puedor apetecan por la gloria de mi madre te voy a borrar el cerito no te digo trigo por no llamarte Rodrigor va usté muy cargadoo a wan ahorarr.